September 22, 2023 Comments Off on New patent for Glaxosmithkline drug ZEJULA Posted in: Patent Added Annual Drug Patent Expirations for ZEJULA Zejula is a drug marketed by Glaxosmithkline and is included in two NDAs. It is available from one supplier. There are seven patents protecting…
The post New patent for Glaxosmithkline drug ZEJULA appeared firs…
September 22, 2023 Comments Off on New patent for Tarsus drug XDEMVY Posted in: Patent Added Annual Drug Patent Expirations for XDEMVY Xdemvy is a drug marketed by Tarsus and is included in one NDA. It is available from one supplier. The generic ingredient in XDEMVY…
The post New patent for Tarsus drug XDEMVY appeared first on DrugPatentWatch …